BEAT

$1.30

Post-MarketAs of Mar 17, 8:00 PM UTC

HeartBeam, Inc.

OverviewIntradayAnalysisPROIntelligencePROAsk AIPRO

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$1.30
Potential Upside
5%
Whystock Fair Value$1.37
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryHealth Information Services

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartB...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$52.15M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
-0.80
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-987.32%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.35

Recent News

Moby
Mar 13, 2026

HeartBeam, Inc. Q4 2025 Earnings Call Summary

Moby summary of HeartBeam, Inc.'s Q4 2025 earnings call

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
GuruFocus.com
Mar 13, 2026

HeartBeam Inc (BEAT) Q4 2025 Earnings Call Highlights: Navigating Financial Challenges with ...

HeartBeam Inc (BEAT) reports a $21 million net loss for 2025 but gains momentum with FDA clearance and strategic partnerships.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Motley Fool
Mar 12, 2026

HeartBeam (BEAT) Q4 2025 Earnings Call Transcript

Brian Humbarger, our new Chief Commercial Officer, will provide an overview of our limited commercial launch. Before we dive into updates since our last call in November, I want to remind everyone about our initial product, the HeartBeam, Inc. system and our platform technology.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Associated Press Finance
Dec 12, 2025

BC-Most Active Stocks

Nu Holdings Ltd. 36,506,840 17.06

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MT Newswires
Dec 10, 2025

Sector Update: Health Care Stocks Climb Late Afternoon

Health care stocks rose late Wednesday afternoon with the NYSE Health Care Index adding 1.6% and the

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.